1. EP-1232: Patient-reported toxicity in twice-daily (BID) versus once-daily (OD) chemoradiotherapy for LS-SCLC. (May 2017) Authors: Lodeweges, J.; Niezink, A.; Elzinga, H.; Haan-Stijntjes, E.; Dollekamp, N.; Chouvalova, O.; Ubbels, J.; Woltman-van Iersel, M.; Van der Leest, A.; Langendijk, J.; Widder, J. Journal: Radiotherapy and oncology Issue: Volume 123:(2017:May)Supplement 1 Page Start: S664 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. OC-0503 Phase III trial of Prophylactic Cranial Irradiation with or without Hippocampus Avoidance in SCLC. (April 2019) Authors: Belderbos, J.; Phd, Md; De Ruysscher, D.; De Jaeger, K.; Koppe, F.; Lambrecht, M.; Lievens, Y.; Dieleman, E.; Jaspers, J.; Van Meerbeeck, J.; Ubbels, J.; Kwint, M.; Kuenen, M.; Deprez, S.; De Ruiter, M.; Sikorska, K.; Van Tinteren, H.; Schagen, S. Journal: Radiotherapy and oncology Issue: Volume 133(2019)Supplement 1 Page Start: S259 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗